For the year ending 2025-12-31, ANTX has $61,950K in assets. $8,890K in debts. $19,941K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 19,941 | |||
| Short-term investments | 38,060 | |||
| Prepaid expenses and other current assets | 1,936 | |||
| Total current assets | 59,937 | |||
| Long-term investments | 2,013 | |||
| Other assets, long-term | 0 | |||
| Total assets | 61,950 | |||
| Accounts payable | 3,021 | |||
| Accrued compensation | 2,418 | |||
| Accrued liabilities | 2,052 | |||
| Other current liabilities | 1,229 | |||
| Total current liabilities | 8,720 | |||
| Other non-current liabilities | 170 | |||
| Total liabilities | 8,890 | |||
| Additional paid-in capital | 293,953 | |||
| Accumulated other comprehensive gain | 57 | |||
| Accumulated deficit | -240,950 | |||
| Total stockholders' equity | 53,060 | |||
| Total liabilities and stockholders' equity | 61,950 | |||
AN2 Therapeutics, Inc. (ANTX)
AN2 Therapeutics, Inc. (ANTX)